Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years
Open Access
- 1 September 2001
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 114 (3), 600-607
- https://doi.org/10.1046/j.1365-2141.2001.02976.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 30 references indexed in Scilit:
- The role of autologous transplantation in patients with multiple myeloma aged 65 years and overBone Marrow Transplantation, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Using at least 5×106/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantationBone Marrow Transplantation, 1999
- Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myelomaBone Marrow Transplantation, 1998
- Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatmentBone Marrow Transplantation, 1997
- Peripheral stem cell mobilization and engraftment in patients over age 60Bone Marrow Transplantation, 1997
- Treatment of Multiple Myeloma in Elderly People: Long-term Results in 178 PatientsAge and Ageing, 1996
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- Acute phase proteins and prognosis in multiple myelomaBritish Journal of Haematology, 1993
- Systemic treatment of cancer in the elderlyArchives of Gerontology and Geriatrics, 1988